Hbk Investments L P Innoviva, Inc. Transaction History

Hbk Investments L P

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	BUY	$13.44 - $17.59 $1.8 Million - $2.35 Million	133,875 Added 176.09%	209,900 $2.9 Million
Q1 2018 May 15, 2018	BUY	$13.8 - $16.99 $805,423 - $991,604	58,364 Added 330.47%	76,025 $1.27 Million
Q4 2017 Feb 14, 2018	BUY	$11.73 - $14.75 $17,137 - $21,549	1,461 Added 9.02%	17,661 $251,000
Q3 2017 Nov 14, 2017	BUY	$12.06 - $14.12 $195,372 - $228,744	16,200	16,200 $229,000

228

79.1M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.32B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.